GoPro Inc.
GPRO · NASDAQ
$0.02 today
- Mkt cap $143.28M
- P/E 0.0
- Day $0.60 – $0.64
Confidence
High conviction
The read
GoPro missed EPS materially, while a 9.6% rebound left the sale-process thesis intact but unconfirmed
GoPro reported a $0.23 loss per share versus a $0.04 estimated loss on August 10. The stock later rose 9.6% to $0.6302 on August 13, despite weak operating indicators, including a -14.96% operating margin, -21.02% trailing revenue growth, and a 14.36% short float. The investment case remains primarily dependent on the strategic review outcome rather than demonstrated operating improvement.
Confidence note: Reported EPS and price data were available, but explicit guidance, event-day reaction data, and post-earnings news were unavailable.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
A favorable strategic-review outcome could validate GoPro as a sale-process investment despite the reported operating deterioration.
- The strategic review produces a transaction or other concrete outcome favorable to shareholders.
- The next quarterly report shows revenue stabilization and improvement from the -14.96% operating margin.
The stock remains driven by sale-process headlines while weak profitability and below-average moving-average positioning limit fundamental support.
- The strategic review continues without a definitive outcome.
- The next report does not establish improvement from -21.02% trailing revenue growth or the -14.96% operating margin.
A failed sale process or another weak product cycle could extend the decline, deepen losses, and increase financing pressure.
- The strategic review produces no favorable outcome.
- The next quarterly report shows continued revenue deterioration and losses following the $0.23 reported EPS loss.
What to do
If you hold it
If you're watching
Add to Watchlist
- Strategic review outcome, identified as the primary catalyst.
- Next quarterly revenue versus the -21.02% trailing growth rate.
- Next quarterly operating margin versus -14.96%.
- Price recovery relative to the $0.8041 20-day SMA and $1.1282 50-day SMA.